Skip to main content
SpringerLink
Log in

Long-Term Outcome of Chronic Dialysis in Children

  • Chapter
  • First Online:
Pediatric Dialysis

  • 776 Accesses

Abstract

Kidney transplantation, and preferably preemptive transplantation, is widely accepted as the optimal mode of renal replacement therapy (RRT) in all children with end-stage kidney disease (ESKD). For this reason, data on the long-term outcome of dialysis in children are scarce. Yet, as most patients with ESKD have to undergo chronic dialysis while waiting for kidney transplantation, and some patients require dialysis for a long time, it is of imminent importance to evaluate the impact of long-term dialysis on the physical and psychosocial condition and development of children with ESKD.

This chapter reviews the potential hazards of long-term dialysis in children based on pathophysiology, adult data and the scarce pediatric epidemiological data that exist on the topic. While mortality in patients with pediatric-onset ESKD during the course of peritoneal dialysis (PD) and hemodialysis (HD) has decreased over the recent decades, mortality risk remains extremely high as compared to the general population. The morbidity associated with long-term dialysis is also examined in this chapter, focusing on cardiovascular disease, chronic kidney disease-mineral bone disorder, psychosocial development, and cognitive functioning. We also pay special attention to one of the most life-threatening late technical complications of PD: encapsulating peritoneal sclerosis (EPS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. SR A. VIII. Pediatric end-stage renal disease. Am J Kidney Dis. 1999;34:S102–13.

    Article  Google Scholar 

  2. Neu AM, Ho PL, McDonald RA, Warady BA. Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol. 2002;17:656–63.

    Article  PubMed  Google Scholar 

  3. Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS study. North American Pediatric Renal Transplant Cooperative Study. Transplantation. 2000;69:1414–9.

    Article  CAS  PubMed  Google Scholar 

  4. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2654–62.

    Article  CAS  PubMed  Google Scholar 

  5. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 2002 Feb;61(2):621–9. https://doi.org/10.1046/j.1523-1755.2002.0015.

    Article  PubMed  Google Scholar 

  6. Shroff R, Ledermann S. Long-term outcome of chronic dialysis in children. Pediatr Nephrol. 2009;24:463–74.

    Article  PubMed  PubMed Central  Google Scholar 

  7. United State Renal Data System 2016 annual data report. Chapter 8: ESRD Among Children, Adolescents, and young Adults, 2016.

    Google Scholar 

  8. Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Ambuhl PM, Andrusev AM, Fuster EA, Arribas Monzon FE, Asberg A, Barbullushi M, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, des Grottes JM, Garneata L, Golan E, Hemmelder MH, Ioannou K, Jarraya F, Kolesnyk M, Komissarov K, Lassalle M, Macario F, Mahillo-Duran B, Martin de Francisco AL, Palsson R, Pechter U, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Simic Ogrizovic S, Slon Roblero MF, Spustova V, Stojceva-Taneva O, Traynor J, Massy ZA, Jager KJ. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J. 2018;11:108–22.

    Google Scholar 

  9. United States renal data system. 2017 annual data report. 2017;2; End-Stage Renal Disease in the United States.

    Google Scholar 

  10. United States renal data system. 2018 annual data report. 2018; 2: End-Stage Renal Disease in the United States.

    Google Scholar 

  11. ESPN/ERA-EDTA Registry. 2018.

    Google Scholar 

  12. ERA-EDTA Registry Annual Report 2016.

    Google Scholar 

  13. Zagozdzon I, Zurowska A, Prokurat S, Rubik J, Drozdz D, Szczepanska M, Warzywoda A, Jander A, Ziolkowska H, Makulska I, Bienias B, Kipigroch H, Wiercinski R, Siten G. Do children with end-stage renal disease live shorter? Analysis of mortality on the basis of data from the Polish Registry of Renal Replacement Therapy in Children. Adv Med Sci. 2015;60:13–7.

    Article  PubMed  Google Scholar 

  14. Hattori M, Sako M, Kaneko T, Ashida A, Matsunaga A, Igarashi T, Itami N, Ohta T, Gotoh Y, Satomura K, Honda M, Igarashi T. End-stage renal disease in Japanese children: a nationwide survey during 2006-2011. Clin Exp Nephrol. 2015;19:933–8.

    Article  PubMed  Google Scholar 

  15. Plumb L, Wong E, Casula A, Braddon F, Lewis M, Marks SD, Shenoy M, Sinha MD, Maxwell H. Chapter 4 demography of the UK Paediatric renal replacement therapy population in 2016. Nephron. 2018;139(Suppl 1):105–16.

    Article  CAS  PubMed  Google Scholar 

  16. Australia and New Zealand Dialysis and Transplantation Registry Annual Report. 2017;Chapter 11; End-stage kidney disease in pediatrics.

    Google Scholar 

  17. CORR Annual report: treatment of end-stage organ failure in Canada, 2004 to 2013. 2015.

    Google Scholar 

  18. Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel-Aguirre A, Soo A, Hemmelgarn BR. Survival in pediatric dialysis and transplant patients. Clin J Am Soc Nephrol. 2011;6:1094–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Verrina E, Edefonti A, Gianoglio B, Rinaldi S, Sorino P, Zacchello G, Lavoratti G, Maringhini S, Pecoraro C, Calevo MG, Turrini Dertenois L, Perfumo F. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol. 2004;19:82–90.

    Article  PubMed  Google Scholar 

  20. Adamczuk D, Roszkowska-Blaim M. Long-term outcomes in children with chronic kidney disease stage 5 over the last 40 years. Arch Med Sci. 2017;13:635–44.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Vogelzang JL, van Stralen KJ, Jager KJ, Groothoff JW. Trend from cardiovascular to non-cardiovascular late mortality in patients with renal replacement therapy since childhood. Nephrol Dial Transplant. 2013;28(8):2082–9. https://doi.org/10.1093/ndt/gft048. Epub 2013

    Article  PubMed  Google Scholar 

  22. Chesnaye NC, Schaefer F, Groothoff JW, Bonthuis M, Reusz G, Heaf JG, Lewis M, Maurer E, Paripovic D, Zagozdzon I, van Stralen KJ, Jager KJ. Mortality risk in European children with end-stage renal disease on dialysis. Kidney Int. 2016;89:1355–62.

    Article  PubMed  Google Scholar 

  23. Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA. 2013;309:1921–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lin HH, Tsai CW, Lin PH, Cheng KF, Wu HD, Wang IK, Lin CY, Chen W, Huang CC. Survival analysis of pediatric dialysis patients in Taiwan. Nephrology (Carlton). 2012;17:621–7.

    Article  Google Scholar 

  25. North American Pediatric Renal Trial and Collaboration Studies. NAPRTCS Annual Report 2011.

    Google Scholar 

  26. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–5.

    Article  PubMed  Google Scholar 

  27. Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002;62:648–53.

    Article  PubMed  Google Scholar 

  28. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–9.

    Article  CAS  PubMed  Google Scholar 

  29. North American Pediatric Renal Trial and Collaboration Studies. NAPRTCS Annual Report: renal transplantation, dialysis, chronic renal insufficiency. 2008.

    Google Scholar 

  30. Honda M, Warady BA. Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2010;25:75–81.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Youssef DM, Neemat-Allah MA. Hemodialysis in children: eleven years in a single center in Egypt. Iran J Kidney Dis. 2013;7(6):468–74. [26].

    Google Scholar 

  32. Chesnaye NC, Schaefer F, Bonthuis M, Holman R, Baiko S, Baskın E, Bjerre A, Berbeca O, Cloarec S, Cornelissen EAM, Espinosa L, Heaf J, Stone R, Shtiza D, Zagozdzon I, Harambat J, Jager KJ, Groothoff JW, van Stralen KJ. Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe. An ESPN-ERA/EDTA Registry analysis. Lancet. 2017;389:pii: S0140-6736(17)30063-6.

    Article  Google Scholar 

  33. Schoenmaker NJ, Tromp WF, van der Lee JH, Adams B, Bouts AH, Collard L, Cransberg K, Van Damme-Lombaerts R, Godefroid N, Van Hoeck KJ, Koster-Kamphuis L, Lilien MR, Ann Raes A, Groothoff JW. Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents. Pediatr Nephrol. 2012;27:1369–79;

    Google Scholar 

  34. Tjaden LA, Noordzij M, van Stralen KJ, Kuehni CE, Raes A, Cornelissen EA, O’Brien C, Papachristou F, Schaefer F, Groothoff JW, Jager KJ, ESPN/ERA-EDTA Registry Study Group. Racial disparities in access to and outcomes of kidney transplantation in children, adolescents, and young adults: results from the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European renal association-European Dialysis and Transplant Association) registry. Am J Kidney Dis. 2016;67(2):293–301.

    Article  PubMed  Google Scholar 

  35. Vidal E, van Stralen KJ, Chesnaye NC, Bonthuis M, Holmberg C, Zurowska A, Trivelli A, Da Silva JEE, Herthelius M, Adams B, Bjerre A, Jankauskiene A, Miteva P, Emirova K, Bayazit AK, Mache CJ, Sanchez-Moreno A, Harambat J, Groothoff JW, Jager KJ, Schaefer F, Verrina E. Infants requiring maintenance dialysis: outcomes of hemodialysis and peritoneal dialysis. Am J Kidney Dis. 2017;69:617–25.

    Article  PubMed  Google Scholar 

  36. Weaver DJ Jr, Somers MJG, Martz K, Mitsnefes MM. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol. 2017;32:2319–30.

    Article  PubMed  Google Scholar 

  37. Honda M. The 1997 report of the Japanese National Registry data on pediatric peritoneal dialysis patients. Perit Dial Int. 1999;19(Suppl 2):S473–8.

    Article  PubMed  Google Scholar 

  38. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005;68:818–25.

    Article  PubMed  Google Scholar 

  39. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97:1514–21.

    Article  CAS  PubMed  Google Scholar 

  40. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:S16–23.

    CAS  PubMed  Google Scholar 

  41. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2005;45:A5–7, s1–280.

    Google Scholar 

  42. European Best Practice Guidelines Expert Group on Hemodialysis Section VII. Vascular disease and risk factors. Nephrol Dial Transplant. 2002;17(Suppl 7):88–109.

    Google Scholar 

  43. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–153.

    Google Scholar 

  44. Wang AY, Sanderson JE. Current perspectives on diagnosis of heart failure in long-term dialysis patients. Am J Kidney Dis. 2011;57:308–19.

    Article  PubMed  Google Scholar 

  45. Nolan CR. Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol. 2005;16(Suppl 2):S120–7.

    Article  PubMed  Google Scholar 

  46. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis. 2005;46:897–902.

    Article  PubMed  Google Scholar 

  47. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14:159–68.

    Article  PubMed  Google Scholar 

  48. Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J. 1992;67:236–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23:2552–7.

    Article  PubMed  Google Scholar 

  50. Goothoff JW, Gruppen MP, Offringa M, de Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van de Kar NC, Wolff ED, Heymans HS. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol. 2002;13(12):2953–61. https://doi.org/10.1097/01.asn.0000037677.16961.df.

    Article  Google Scholar 

  51. Xie Q, Ge X, Shang D, Li Y, Yan H, Tian J, Hao CM, Zhu T. Coronary artery calcification score as a predictor of all-cause mortality and cardiovascular outcome in peritoneal Dialysis patients. Perit Dial Int. 2016;36:163–70.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Querfeld U, Schaefer F. Cardiovascular risk factors in children on dialysis: an update. Pediatr Nephrol. 2018;35:41–57.

    Article  PubMed  Google Scholar 

  53. Al-Biltagi M, ElHafez MAA, El Amrousy DM, El-Gamasy M, El-Serogy H. Evaluation of the coronary circulation and calcification in children on regular hemodialysis. Pediatr Nephrol. 2017;32:1941–51.

    Article  PubMed  Google Scholar 

  54. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–83.

    Article  CAS  PubMed  Google Scholar 

  55. Srivaths PR, Silverstein DM, Leung J, Krishnamurthy R, Goldstein SL. Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis. Hemodial Int. 2010;14:263–9.

    Article  PubMed  Google Scholar 

  56. Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, Zambrano P, Ahlenstiel T, Bakkaloglu SA, Spizzirri AP, Lopez L, Ozaltin F, Printza N, Hari P, Klaus G, Bak M, Vogel A, Ariceta G, Yap HK, Warady BA, Schaefer F. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010;78:1295–304.

    Article  PubMed  Google Scholar 

  57. Groothoff JW, Offringa M, Van Eck-Smit BL, Gruppen MP, Van De Kar NJ, Wolff ED, Lilien MR, Davin JC, Heymans HS, Dekker FW. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int. 2003;63:266–75.

    Article  PubMed  Google Scholar 

  58. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009;5:185–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Harambat J, Bonthuis M, van Stralen KJ, Ariceta G, Battelino N, Bjerre A, Jahnukainen T, Leroy V, Reusz G, Sandes AR, Sinha MD, Groothoff JW, Combe C, Jager KJ, Verrina E, Schaefer F, ESPN/ERA-EDTA Registry. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol. 2014;9(1):92–9.

    Article  PubMed  Google Scholar 

  60. van Huis M, Bonthuis M, Sahpazova E, Mencarelli F, Spasojević B, Reusz G, Caldas-Afonso A, Bjerre A, Baiko S, Vondrak K, Molchanova EA, Kolvek G, Zaikova N, Böhm M, Ariceta G, Jager KJ, Schaefer F, van Stralen KJ, Groothoff JW. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant. 2015;31(4):609–19. pii: gfv105

    Article  PubMed  Google Scholar 

  61. Tanno Y, Yokoyama K, Hosoya T. Laparoscopic approach for the evaluation of peritoneal injury. Kidney Int. 2012;82:244–5.

    Article  PubMed  Google Scholar 

  62. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol. 2008;3:720–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Tawada M, Ito Y, Hamada C, Honda K, Mizuno M, Suzuki Y, Sakata F, Terabayashi T, Matsukawa Y, Maruyama S, Imai E, Matsuo S, Takei Y. Vascular endothelial cell injury is an important factor in the development of encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients. PLoS One. 2016;11:e0154644.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Yamamoto T, Izumotani T, Otoshi T, Kim M. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance. Am J Kidney Dis. 1998;32:946–52.

    Article  CAS  PubMed  Google Scholar 

  65. Johnson DW, Mudge DW, Blizzard S, Arndt M, O'Shea A, Watt R, Hamilton J, Cottingham S, Isbel NM, Hawley CM. A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement. Perit Dial Int. 2004;24:460–5.

    Article  PubMed  Google Scholar 

  66. Rubin J, Ray R, Barnes T, Bower J. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron. 1981;29:124–7.

    Article  CAS  PubMed  Google Scholar 

  67. Albrektsen GE, Wideroe TE, Nilsen TI, Romundstad P, Radtke M, Hallan S, Aasarod K, Oien C, Laegreid IK. Transperitoneal water transport before, during, and after episodes with infectious peritonitis in patients treated with CAPD. Am J Kidney Dis. 2004;43:485–91.

    Article  PubMed  Google Scholar 

  68. Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Investig. 1987;17:43–52.

    Article  CAS  Google Scholar 

  69. Lai KN, Leung JC. Inflammation in peritoneal dialysis. Nephron Clin Pract. 2010;116:c11–8.

    Article  CAS  PubMed  Google Scholar 

  70. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int. 2004;66:2437–45.

    Article  CAS  PubMed  Google Scholar 

  71. Holtta TM, Ronnholm KA, Holmberg C. Influence of age, time, and peritonitis on peritoneal transport kinetics in children. Perit Dial Int. 1998;18:590–7.

    Article  CAS  PubMed  Google Scholar 

  72. Warady BA, Fivush B, Andreoli SP, Kohaut E, Salusky I, Schlichting L, Pu K, Watkins S. Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis. Pediatr Nephrol. 1999;13:571–6.

    Article  CAS  PubMed  Google Scholar 

  73. Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, Tanaka Y, Kawamura K, Murai T, Kamiyama Y. Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis-free children. Perit Dial Int. 2001;21:180–5.

    Article  CAS  PubMed  Google Scholar 

  74. Kaku Y, Honda M. Standardized peritoneal equilibration test in Japanese children and the influence of long-term peritoneal dialysis. Perit Dial Int. 2008;28(Suppl 3):S150–2.

    Article  CAS  PubMed  Google Scholar 

  75. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25(Suppl 4):S19–29.

    Article  PubMed  Google Scholar 

  76. Van Overmeire L, Goffin E, Krzesinski JM, Saint-Remy A, Bovy P, Cornet G, Bovy C. Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product’ or with biocompatible ‘normal pH/low glucose degradation product’ dialysates: does it matter? Nephrol Dial Transplant. 2013;28:1946–51.

    Article  PubMed  CAS  Google Scholar 

  77. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, Kim BS, Park HC, Choi KH, Ha SK, Han DS, Lee HY. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int. 2008;28:174–82.

    Article  CAS  PubMed  Google Scholar 

  78. Ayuzawa N, Ishibashi Y, Takazawa Y, Kume H, Fujita T. Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan. Perit Dial Int. 2012;32:159–67.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66:408–18.

    Article  PubMed  Google Scholar 

  80. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi M, Tan SH, Voss D. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol. 2012;23:1097–107.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Yamagata K, Tomida C, Koyama A. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1999;19:131–7.

    Article  CAS  PubMed  Google Scholar 

  82. Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int. 2005;25(Suppl 4):S14–8.

    Article  PubMed  Google Scholar 

  83. Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis–a multicentre study in Japan. Nephrol Dial Transplant. 2007;22:560–7.

    Article  CAS  PubMed  Google Scholar 

  84. Do JY, Kim YL, Park JW, Chang KA, Lee SH, Ryu DH, Kim CD, Park SH, Yoon KW. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis. Perit Dial Int. 2008;28(Suppl 3):S101–6.

    Article  PubMed  Google Scholar 

  85. Homma S, Masunaga Y, Kurosu M, Inoue M, Sakurai T, Asano Y. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis. Perit Dial Int. 2002;22:178–83.

    Article  PubMed  Google Scholar 

  86. Morelle J, Sow A, Hautem N, Bouzin C, Crott R, Devuyst O, Goffin E. Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis. J Am Soc Nephrol. 2015;26:2521–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Yokoyama K, Yoshida H, Matsuo N, Maruyama Y, Kawamura Y, Yamamoto R, Hanaoka K, Ikeda M, Yamamoto H, Nakayama M, Kawaguchi Y, Hosoya T. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients. Clin Nephrol. 2008;69:121–6.

    Article  CAS  PubMed  Google Scholar 

  88. Izumotani T, Ishimura E, Yamamoto T, Otoshi T, Okuno S, Inaba M, Kim M, Nishizawa Y. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis. Nephron. 2001;89:43–9.

    Article  CAS  PubMed  Google Scholar 

  89. Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Exp Nephrol. 2004;8:339–43.

    Article  CAS  PubMed  Google Scholar 

  90. Kawanishi H, Fujimori A, Tsuchida K, Takemoto Y, Tomo T, Minakuchi J, Yamamoto T, Kim M, Numata A, Choh S, Naito H. Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan. Adv Perit Dial Conf Perit Dial. 2005;21:134–8.

    Google Scholar 

  91. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int. 1997;51:888–93.

    Article  CAS  PubMed  Google Scholar 

  92. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, Tranaeus A. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int. 2005;25(Suppl 4):S83–95.

    Article  PubMed  Google Scholar 

  93. Brown MC, Simpson K, Kerssens JJ, Mactier RA. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol. 2009;4:1222–9.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Shroff R, Stefanidis CJ, Askiti V, Edefonti A, Testa S, Ekim M, Kavaz A, Ariceta G, Bakkaloglu S, Fischbach M, Klaus G, Zurowska A, Holtta T, Jankauskiene A, Vondrak K, Vande Walle J, Schmitt CP, Watson AR. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant. 2013;28:1908–14.

    Article  CAS  PubMed  Google Scholar 

  95. Hoshii S, Honda M. High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years. Perit Dial Int. 2002;22:730–1.

    Article  CAS  PubMed  Google Scholar 

  96. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, Rosman JB, Bannister KM, Wiggins KJ. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 2010;77:904–12.

    Article  PubMed  Google Scholar 

  97. Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, Farrington K, Gallagher H, Harnett P, Krausze S, Steddon S. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24:3209–15.

    Article  PubMed  Google Scholar 

  98. Kawanishi K, Honda K, Hamada C. Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients. Pleura Peritoneum. 2017;2:3–15.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004;65:1927–36.

    Article  CAS  PubMed  Google Scholar 

  100. Schilte MN, Celie JW, Wee PM, Beelen RH, van den Born J. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int. 2009;29:605–17.

    Article  CAS  PubMed  Google Scholar 

  101. Aguilera A, Yanez-Mo M, Selgas R, Sanchez-Madrid F, Lopez-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs (London, England: 2000). 2005;6:262–8.

    CAS  Google Scholar 

  102. Holmdahl L, Kotseos K, Bergstrom M, Falk P, Ivarsson ML, Chegini N. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Surgery. 2001;129:626–32.

    Article  CAS  PubMed  Google Scholar 

  103. Vidal E, Edefonti A, Puteo F, Chimenz R, Gianoglio B, Lavoratti G, Leozappa G, Maringhini S, Mencarelli F, Pecoraro C, Ratsch IM, Cannavo R, De Palo T, Testa S, Murer L, Verrina E. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrol Dial Transplant. 2013;28:1603–9.

    Article  CAS  PubMed  Google Scholar 

  104. Otsuka Y, Nakayama M, Ikeda M, Sherif AM, Yokoyama K, Yamamoto H, Kawaguchi Y. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis. Clin Exp Nephrol. 2005;9:315–9.

    Article  PubMed  Google Scholar 

  105. Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int. 2010;78:611–8.

    Article  PubMed  Google Scholar 

  106. Yamamoto T, Nagasue K, Okuno S, Yamakawa T. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int. 2010;30:343–52.

    Article  PubMed  Google Scholar 

  107. Barreto DL, Coester AM, Struijk DG, Krediet RT. Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? Perit Dial Int. 2013;33:529–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Sampimon DE, Korte MR, Barreto DL, Vlijm A, de Waart R, Struijk DG, Krediet RT. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int. 2010;30:163–9.

    Article  CAS  PubMed  Google Scholar 

  109. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4):S43–55.

    Article  PubMed  Google Scholar 

  110. Rottembourg J, Brouard R, Issad B, Allouache M, Ghali B, Boudjemaa A. Role of acetate in loss of ultrafiltration during CAPD. Contrib Nephrol. 1987;57:197–206.

    Article  CAS  PubMed  Google Scholar 

  111. Parikova A, Zweers MM, Struijk DG, Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial Conf Perit Dial. 2003;19:186–90.

    Google Scholar 

  112. Moriishi M, Kawanishi H. Icodextrin and intraperitoneal inflammation. Perit Dial Int. 2008;28(Suppl 3):S96–s100.

    Article  CAS  PubMed  Google Scholar 

  113. Kawanishi H, Shintaku S, Shishida M, Morrishi M, Tsuchiya S, Dohi K. A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution. Adv Perit Dial Conf Perit Dial. 2009;25:45–9.

    Google Scholar 

  114. Habib AM, Preston E, Davenport A. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant. 2010;25:1633–8.

    Article  CAS  PubMed  Google Scholar 

  115. Klink CD, Schickhaus P, Binnebosel M, Jockenhoevel S, Rosch R, Tolba R, Neumann UP, Klinge U. Influence of 4% icodextrin solution on peritoneal tissue response and adhesion formation. BMC Surg. 2013;13:34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  116. Nakayama M, Miyazaki M, Honda K, Kasai K, Tomo T, Nakamoto H, Kawanishi H. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Perit Dial Int. 2014;34:766–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int. 2013;33:242–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Hamada C, Honda K, Kawanishi K, Nakamoto H, Ito Y, Sakurada T, Tanno Y, Mizumasa T, Miyazaki M, Moriishi M, Nakayama M. Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution. J Artif Organs. 2015;18:243–50.

    Article  CAS  PubMed  Google Scholar 

  119. Hoshii S, Honda M, Itami N, Oh S, Matsumura C, Moriya S, Mori M, Hatae K, Ito Y, Karashima S. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol. 2000;14:275–9.

    Article  CAS  PubMed  Google Scholar 

  120. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis. 1996;28:420–7.

    Article  CAS  PubMed  Google Scholar 

  121. Nakayama M. The greater incidence of encapsulating peritoneal sclerosis is not the result of overdiagnosis. Perit Dial Int. 2001;21(Suppl 3):S72–4.

    Article  PubMed  Google Scholar 

  122. Hsu YH, Hsia CC, Tsai DM, Tu HY, Hung KY, Huang JW. Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient. Am J Kidney Dis. 2010;55:198–202.

    Article  PubMed  Google Scholar 

  123. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729–37.

    Article  PubMed  Google Scholar 

  124. van Westrhenen R, Aten J, Hajji N, de Boer OJ, Kunne C, de Waart DR, Krediet RT. Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat. Blood Purif. 2007;25:466–72.

    Article  PubMed  CAS  Google Scholar 

  125. da Silva N, Rocha S, Rocha L, Faria S, Costa T, Mota C. Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient. Pediatr Nephrol. 2012;27:1583–8.

    Article  PubMed  Google Scholar 

  126. Tan R, Betjes M, Cransberg K. Post-transplantation encapsulating peritoneal sclerosis in a young child. Nephrol Dial Transplant. 2011;26:3822–4.

    Article  PubMed  Google Scholar 

  127. Maluccio M, Sharma V, Lagman M, Vyas S, Yang H, Li B, Suthanthiran M. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation. 2003;76:597–602.

    Article  CAS  PubMed  Google Scholar 

  128. Korte MR, Habib SM, Lingsma H, Weimar W, Betjes MG. Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11:599–605.

    Article  CAS  Google Scholar 

  129. Temple S, Zaltzman J, Perl J. Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy. Perit Dial Int. 2010;30:475–7.

    Article  CAS  PubMed  Google Scholar 

  130. Sud R, Garry L, Spicer ST, Allen RD, Eris JM, Wyburn K, Verran D, Cooper CL, Chadban S. A role for everolimus in post-transplant encapsulating peritoneal sclerosis: first case report. Nephrology (Carlton). 2014;19(Suppl 1):27–30.

    Article  Google Scholar 

  131. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, Watanabe H, Takahashi N. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. Adv Perit Dial Conf Perit Dial. 2002;18:149–53.

    Google Scholar 

  132. Brown P, Baddeley H, Read AE, Davies JD, McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (London, England). 1974;2:1477–81.

    Article  CAS  Google Scholar 

  133. Oules R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant. 1988;3:66–9.

    CAS  PubMed  Google Scholar 

  134. Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis – position paper for ISPD: 2017 update. Perit Dial Int. 2017;37:362–74.

    Google Scholar 

  135. Nakamoto H. Encapsulating peritoneal sclerosis–a clinician’s approach to diagnosis and medical treatment. Perit Dial Int. 2005;25(Suppl 4):S30–8.

    Article  PubMed  Google Scholar 

  136. Sampimon DE, Coester AM, Struijk DG, Krediet RT. The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2011;26:291–8.

    Article  PubMed  Google Scholar 

  137. Goodlad C, Tarzi R, Gedroyc W, Lim A, Moser S, Brown EA. Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning. Nephrol Dial Transplant. 2011;26:1374–9.

    Article  PubMed  Google Scholar 

  138. Tarzi RM, Lim A, Moser S, Ahmad S, George A, Balasubramaniam G, Clutterbuck EJ, Gedroyc W, Brown EA. Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol. 2008;3:1702–10.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SS, Maes R, Struijk DG, Krediet RT. Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int. 2009;29:517–22.

    Article  PubMed  Google Scholar 

  140. Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, Honda M. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int. 2000;20:445–51.141,142.

    Google Scholar 

  141. Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001;16:1304–5.

    Article  CAS  PubMed  Google Scholar 

  142. Mori Y, Matsuo S, Sutoh H, Toriyama T, Kawahara H, Hotta N. A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone. Am J Kidney Dis. 1997;30:275–8.

    Article  CAS  PubMed  Google Scholar 

  143. Habib SM, Betjes MG, Fieren MW, Boeschoten EW, Abrahams AC, Boer WH, Struijk DG, Ruger W, Krikke C, Westerhuis R, de Sevaux RG, van der Sande FM, Gaasbeek A, Korte MR. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med. 2011;69:500–7.

    CAS  PubMed  Google Scholar 

  144. van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144:101–6.

    Article  PubMed  Google Scholar 

  145. Loureiro J, Sandoval P, del Peso G, Gonzalez-Mateo G, Fernandez-Millara V, Santamaria B, Bajo MA, Sanchez-Tomero JA, Guerra-Azcona G, Selgas R, Lopez-Cabrera M, Aguilera AI. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One. 2013;8:e61165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Huang JW, Yen CJ, Wu HY, Chiang CK, Cheng HT, Lien YC, Hung KY, Tsai TJ. Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis. Blood Purif. 2011;31:252–8.

    Article  CAS  PubMed  Google Scholar 

  147. Guest S. Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences. Perit Dial Int. 2009;29:252–5.

    Article  CAS  PubMed  Google Scholar 

  148. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant. 2011;26:691–7.

    Article  CAS  PubMed  Google Scholar 

  149. Woodrow G, Fan SL, Reid C, Denning J, Pyrah AN. Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children. BMC Nephrol. 2017;18:333.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg (Chicago, Ill: 1960). 1990;125:1626–8.

    Article  CAS  Google Scholar 

  151. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25(Suppl 4):S39–47.

    Article  PubMed  Google Scholar 

  152. Kawanishi H, Shintaku S, Moriishi M, Dohi K, Tsuchiya S. Seventeen years’ experience of surgical options for encapsulating peritoneal sclerosis. Adv Perit Dial Conf Perit Dial. 2011;27:53–8.

    Google Scholar 

  153. Kawanishi H. Surgical treatment for encapsulating peritoneal sclerosis. Adv Perit Dial Conf Perit Dial. 2002;18:139–43.

    Google Scholar 

  154. Campbell R, Augustine T, Hurst H, Pararajasingam R, van Dellen D, Armstrong S, Bartley C, Birtles L, Summers A. Anthropometrics identify wasting in patients undergoing surgery for encapsulating peritoneal sclerosis. Perit Dial Int. 2015;35:471–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Latus J, Ulmer C, Fritz P, Rettenmaier B, Biegger D, Lang T, Ott G, Scharpf C, Kimmel M, Steurer W, Alscher MD, Braun N. Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral Centre in Germany. Nephrol Dial Transplant. 2013;28:1021–30.

    Article  PubMed  Google Scholar 

  156. Betjes MG, Habib SM, Boeschoten EW, Hemke AC, Struijk DG, Westerhuis R, Abrahams AC, Korte MR. Significant decreasing incidence of encapsulating peritoneal sclerosis in the Dutch population of peritoneal dialysis patients. Perit Dial Int. 2017;37:230–4.

    Article  PubMed  Google Scholar 

  157. El-Sherbini N, Duncan N, Hickson M, Johansson L, Brown EA. Nutrition changes in conservatively treated patients with encapsulating peritoneal sclerosis. Perit Dial Int. 2013;33:538–43.

    Article  PubMed  PubMed Central  Google Scholar 

  158. de Freitas D, Jordaan A, Williams R, Alderdice J, Curwell J, Hurst H, Hutchison A, Brenchley PE, Augustine T, Summers AM. Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28:271–6.

    Article  PubMed  Google Scholar 

  159. Stefanidis CJ, Shroff R. Encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2014;29:2093–103.

    Article  PubMed  Google Scholar 

  160. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998;13:154–9.

    Article  CAS  PubMed  Google Scholar 

  161. Kawanishi H. Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study. Perit Dial Int. 2001;21(Suppl 3):S67–71.

    Article  PubMed  Google Scholar 

  162. Phelan PJ, Walshe JJ, Al-Aradi A, Garvey JP, Finnegan K, O’Kelly P, McWilliams J, Ti JP, Morrin MM, Morgan N, Conlon PJ. Encapsulating peritoneal sclerosis: experience of a tertiary referral center. Ren Fail. 2010;32:459–63.

    Article  CAS  PubMed  Google Scholar 

  163. Bansal S, Sheth H, Siddiqui N, Bender FH, Johnston JR, Piraino B. Incidence of encapsulating peritoneal sclerosis at a single U.S. university center. Adv Perit Dial Conf Perit Dial. 2010;26:75–81.

    Google Scholar 

  164. Vizzardi V, Sandrini M, Zecchini S, Ravera S, Manili L, Cancarini G. Encapsulating peritoneal sclerosis in an Italian center: thirty-year experience. J Nephrol. 2016;29:259–67.

    Article  PubMed  Google Scholar 

  165. Petrie MC, Traynor JP, Mactier RA. Incidence and outcome of encapsulating peritoneal sclerosis. Clin Kidney J. 2016;9:624–9.

    Article  PubMed  PubMed Central  Google Scholar 

  166. Alatab S, Najafi I, Pourmand G, Hosseini M, Shekarchian S. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients. Ren Fail. 2017;39:32–9.

    Article  PubMed  Google Scholar 

  167. Brouhard BH, Donaldson LA, Lawry KW, et al. Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplant. 2000;4:261–7.

    Article  CAS  PubMed  Google Scholar 

  168. Gipson DS, Hooper SR, Duquette PJ, et al. Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol. 2006;12:391–405.

    Article  PubMed  Google Scholar 

  169. Qvist E, Pihko H, Fagerudd P, et al. Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplant. 2002;6:53–62.

    Article  PubMed  Google Scholar 

  170. Broyer M, Le BC, Charbit M, et al. Long-term social outcome of children after kidney transplantation. Transplantation. 2004;77:1033–7.

    Article  PubMed  Google Scholar 

  171. Groothoff JW, Grootenhuis M, Dommerholt A, et al. Impaired cognition and schooling in adults with end stage renal disease since childhood. Arch Dis Child. 2002;87:380–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  172. Bawden HN, Acott P, Carter J, et al. Neuropsychological functioning in end-stage renal disease. Arch Dis Child. 2004;89:644–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  173. Duquette PJ, Hooper SR, Wetherington CE, et al. Brief report: intellectual and academic functioning in pediatric chronic kidney disease. J Pediatr Psychol. 2007;32:1011–7.

    Article  PubMed  Google Scholar 

  174. Karrfelt HM, Berg UB. Long-term psychosocial outcome after renal transplantation during childhood. Pediatr Transplant. 2008;12:557–62.

    Article  PubMed  Google Scholar 

  175. Johnson RJ, Warady BA. Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy. Pediatr Nephrol. 2013;28:1283–91.

    Article  PubMed  Google Scholar 

  176. Hooper SR, Gerson AC, Butler RW, et al. Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1824–30.

    Article  PubMed  PubMed Central  Google Scholar 

  177. Groothoff JW, Grootenhuis MA, Offringa M, Gruppen MP, Korevaar JC, Heymans HSA. Quality of life in adults with end-stage renal disease since childhood is only partially impaired. Nephrol Dial Transplant. 2003;18(2):310–7.

    Article  PubMed  Google Scholar 

  178. Fujisawa M, Ichikawa Y, Yoshiya K, et al. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology. 2000;56:201–6.

    Article  CAS  PubMed  Google Scholar 

  179. Merkus MP, Jager KJ, Dekker FW, et al. Quality of life over time in dialysis: the Netherlands cooperative study on the adequacy of dialysis. NECOSAD Study Group. Kidney Int. 1999;56:720–8.

    Article  CAS  PubMed  Google Scholar 

  180. Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis. 1997;29:584–92.

    Article  CAS  PubMed  Google Scholar 

  181. Gee L, Abbott J, Conway SP, et al. Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis. J Cyst Fibros. 2002;1:137–45.

    Article  CAS  PubMed  Google Scholar 

  182. Lee TA, Hollingworth W, Sullivan SD. Comparison of directly elicited preferences to preferences derived from the SF-36 in adults with asthma. Med Decis Mak. 2003;23:323–34.

    Article  Google Scholar 

  183. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.

    Article  PubMed  PubMed Central  Google Scholar 

  184. Rebollo P, Ortega F, Baltar JM, et al. Is the loss of health-related quality of life during renal replacement therapy lower in elderly patients than in younger patients? Nephrol Dial Transplant. 2001;16:1675–80. 200

    Article  CAS  PubMed  Google Scholar 

  185. Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? BMJ. 2001;322:1240–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  186. Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Maurice-Stam H, Grootenhuis MA, et al. Long-term quality of life and social outcome of childhood end-stage renal disease. J Pediatr. 2014;165(2):336–42.

    Article  PubMed  Google Scholar 

  187. Groothoff JW, Grootenhuis MA, Offringa M, et al. Social consequences in adult life of end-stage renal disease in childhood. J Pediatr. 2005;146:512–7.

    Article  PubMed  Google Scholar 

  188. Tjaden LA, Maurice-Stam H, Grootenhuis MA, Jager KJ, Groothoff JW. Impact of renal replacement therapy in childhood on long-term socioprofessional outcomes: a 30-year follow-up study. J Pediatr. 2016;171:189–95.e1-2. pii: S0022-3476(15)01527-9

    Article  PubMed  Google Scholar 

  189. Rees L, Shroff R, Hutchinson C, Fernando ON, Trompeter RS. Long-term outcome of Paediatric renal transplantation: follow-up of 300 children from 1973 to 2000. Nephron Clin Pract. 2007;105:c68–c7.

    Article  PubMed  Google Scholar 

  190. Rocha S, Fonseca I, Silva N, et al. Impact of pediatric kidney transplantation on long-term professional and social outcomes. Transplant Proc. 2011;43:120–4.

    Article  CAS  PubMed  Google Scholar 

  191. Tozzi AE, Mazzotti E, Di Ciommo VM, et al. Quality of life in a cohort of patients diagnosed with renal failure in childhood and who received renal transplant. Pediatr Transplant. 2012;16:840–5. 201

    Article  PubMed  Google Scholar 

  192. Mellerio H, Alberti C, Labeguerie M, et al. Adult social and professional outcomes of pediatric renal transplant recipients. Transplantation. 2014;97:196–205.

    Article  PubMed  Google Scholar 

  193. Offner G, Latta K, Hoyer PF, et al. Kidney transplanted children come of age. Kidney Int. 1999;55:1509–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Research Support Center, Metropolitan Children’s Medical Center, Tokyo, Japan

    Masataka Honda

  2. Department of Nephrology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan

    Chikako Terano, Tomohiro Inoguchi, Kaori Kikunaga & Ryoko Harada

  3. Pediatric Nephrology Department, Amsterdam UMC/Emma Children’s Hospital, Amsterdam, Netherlands

    Jaap W. Groothoff

Authors
  1. Masataka Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chikako Terano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohiro Inoguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kaori Kikunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ryoko Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jaap W. Groothoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masataka Honda .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Missouri-Kansas City, School of Medicine, Division of Pediatric Nephrology, Children’s Mercy Kansas City, Kansas City, MO, USA

    Bradley A. Warady

  2. Stanford University School of Medicine, Division of Pediatric Nephrology, Department of Pediatrics, Palo Alto, CA, USA

    Steven R. Alexander

  3. Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Honda, M., Terano, C., Inoguchi, T., Kikunaga, K., Harada, R., Groothoff, J.W. (2021). Long-Term Outcome of Chronic Dialysis in Children. In: Warady, B.A., Alexander, S.R., Schaefer, F. (eds) Pediatric Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-030-66861-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-66861-7_39

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-66860-0

  • Online ISBN: 978-3-030-66861-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation